1Bernhard J,Dietrich D,Scheithauer W,et al,Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone:a randomized multicenter phase Ⅲ clinical trial-SAKK 44/00-CECOG/PAN.1.3.001[J].J Clin Oncol,2008,26(22):3695-3701. 被引量：1
2Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403-2413. 被引量：1
3Xiong LL,Hwang JH,Huang XB,et al.Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer[J].JOP,2009,10(2):123-129. 被引量：1
4Wu F,Wang ZB,Zhu H,et al.Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer:initial experience[J].Radiology,2005,236(3):1034-1040. 被引量：1
5Schniewind B,Bestmann B,Kurdow R,et al.Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head,with an emphasis on quality of life analyses.Ann Surg Oncol,2006,13(11):1403-1411. 被引量：1
6Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008.CA Cancer J Clin,2008,58(2):71-96. 被引量：1
7Lall CG,Howard TJ,Skandarajah A,et al.New concepts in staging and treatment of locally advanced pancreatic head cancer.AJR Am J Roentgenol,2007,189(5):1044-1050. 被引量：1
8Callery MP,Chang KJ,Fishman EK,et al.Pretreatment assessment of resectable and borderline resectable pancreatic cancer:expert consensus statement.Ann Surg Oncol,2009,16(7):1727-1733. 被引量：1
9Krishna NB,LaBundy JL,Saripalli S,et al.Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice.Pancreas,2009,38(6):625-630. 被引量：1
10Westgaard A,Tafjord S,Farstad IN,et al.Resectable adenocarcinomas in the pancreatic head:the retroperitoneal resection margin is an independent prognostic factor.BMC Cancer,2008,8:5. 被引量：1
